Clostebol propionate: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
[[Category:Estranes]] | [[Category:Estranes]] | ||
[[Category:World Anti-Doping Agency prohibited substances]] | [[Category:World Anti-Doping Agency prohibited substances]] | ||
<gallery> | |||
File:Clostebol_propionate.svg|Chemical structure of Clostebol propionate | |||
File:Clostebol_propionate_molecule_ball.png|Ball-and-stick model of Clostebol propionate | |||
</gallery> | |||
Latest revision as of 01:32, 18 February 2025
Clostebol propionate is a synthetic androgen and anabolic steroid and a derivative of testosterone in the family of 17β-Hydroxysteroid dehydrogenase inhibitors. It is used in the treatment of hypogonadism and delayed puberty in males and breast cancer in females.
Pharmacology[edit]
Clostebol propionate is a prodrug of clostebol. It is administered via intramuscular injection.
Chemistry[edit]
Clostebol propionate, also known as 4-chlorotestosterone 17β-propionate, is a synthetic androstane steroid and a derivative of testosterone. It is more specifically a derivative of nandrolone (19-nortestosterone) and is a member of the estrane (C18 steroid) family.
History[edit]
Clostebol propionate was first described in 1962 and was introduced for medical use later that year.
Society and culture[edit]
Clostebol propionate has been used in sport to enhance performance, although it is currently banned by the World Anti-Doping Agency.
See also[edit]
References[edit]
<references />
